Sharon Glynn

Associate Professor in Pathology

University of Galway

Ireland

Research Interests

Explore related searches

Professors in Ireland Professors in Immunology Immunology professors in Ireland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sharon Glynn is an Associate Professor in Pathology at the University of Galway, Ireland. Her research focuses on the role of nitric oxide in cancer biology, with recent articles addressing its effects on breast cancer treatment and tumor progression. Notable studies include investigations into hemin derivatives for therapeutic applications and the modulation of cytokine signaling within tumors.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (13)

jenny chang

Professor

Weill Cornell Medical College

UNITED STATES

View details

Gabor Cserni

University of Szeged

HUNGARY

View details

Abhay Pandit

University of Galway

IRELAND

View details

Pau Farras Costa

Lecturer in Inorganic Chemistry

National University of Ireland Galway

IRELAND

View details

Anikó Kovács

University of Gothenburg

SWEDEN

View details

Durgadas Cherukaraveedu

Johns Hopkins University

UNITED STATES

View details

Aideen Ryan

Senior Lecturer

NUI Galway

IRELAND

View details

Peter Regitnig

Medical University of Graz

AUSTRIA

View details

Caterina MARCHIO'

Associate Professor of Pathology

University of Turin

ITALY

View details

Daniel McVicar

Acting Chief

National Cancer Institute

UNITED STATES

View details

David Wink

Acting Deputy Chief

National Cancer Institute

UNITED STATES

View details

Maria P. Foschini

Full Professor of Anatomic Pathology

University of Bologna

ITALY

View details

Douglas Thomas

University of Chicago

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sharon Glynn

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Facile Synthesis of Hemin Derivatives with Modulated Aggregation Behaviour and Enhanced Nitric‐Oxide Scavenging Properties as New Therapeutics for Breast Cancer

Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors.

The impact of nitric oxide on HER family post-translational modification and downstream signaling in cancer.

ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations

Targeting Nitric Oxide: Say NO to Metastasis

Nitric Oxide-Scavenging, Anti-Migration Effects, and Glycosylation Changes after Hemin Treatment of Human Triple-Negative Breast Cancer Cells: A Mechanistic Study

Nitric oxide inhibits FTO demethylase activity to regulate N6-methyladenosine mRNA methylation

Interferon-gamma is quintessential for NOS2 and COX2 expression in ER<sup>-</sup> breast tumors that lead to poor outcome.

Chronic nitric oxide exposure induces prostate cell carcinogenesis, involving genetic instability and a pro-tumorigenic secretory phenotype

Protein nitration induced by Hemin/NO: A complementary mechanism through the catalytic functions of hemin and NO-scavenging

Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density.

Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer

Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment

The Role of Nitric Oxide in Cancer: Master Regulator or NOt?

Collaborators (13)

jenny chang

Gabor Cserni

Abhay Pandit

Pau Farras Costa

Anikó Kovács

Durgadas Cherukaraveedu

Aideen Ryan

Peter Regitnig

Caterina MARCHIO'

Daniel McVicar

David Wink

Maria P. Foschini

Douglas Thomas

Make your next move.